cover
Contact Name
Veri Hardinansyah Dja'far
Contact Email
admin@transpublika.co.id
Phone
+6281234560500
Journal Mail Official
admin@transpublika.co.id
Editorial Address
Jl. Kolonel Sugiono IIIC/438 RT 10/RW 04 Mergosono, , Malang, Provinsi Jawa Timur, 65134
Location
Kota malang,
Jawa timur
INDONESIA
PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID)
Published by Transpublika Publisher
ISSN : -     EISSN : 28099745     DOI : https://doi.org/10.55047/comorbid
Core Subject : Health, Science,
About the Journal PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID) is an international, modern, general medical publication that publishes research on all aspects of medicine, from fundamental research to significant clinical trials and cost-effectiveness analyses. We generally publish human research that contribute to our understanding of medical epidemiology, etiology, and physiology; the development of prognostic and diagnostic technologies; clinical trials that evaluate the efficacy of particular therapies and comparative trials; and systematic reviews. We want to encourage the conversion of fundamental research into clinical trials and clinical evidence into therapeutic practice. When studies in animal models produce remarkable research findings that are extremely clinically relevant, we publish them on occasion. The international medical community, as well as educators, policymakers, patient advocacy groups, and other interested parties, are among our target audiences. The online edition of COMORBID is updated on a regular basis. Medical Informatics, Basic Science, Clinical Science, Case Report, Brief Communication, Public Health, Public Policy, and Review Articles from all branches of medicine and associated subjects are published in PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID)
Articles 3 Documents
Search results for , issue "Vol. 2 No. 2 (2023): APRIL" : 3 Documents clear
THE RELATIONSHIP BETWEEN FAMILY INCOME AND THE NUTRITIONAL STATUS OF PREGNANT MOTHERS AT AMPEL 1 PRIMARY HEALTH CARE CENTER IN BOYOLALI REGENCY Kurnia Rahayu; Alfiah Rahmawati; Is Susiloningtyas
PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID) Vol. 2 No. 2 (2023): APRIL
Publisher : Transpublika Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55047/comorbid.v2i2.820

Abstract

Pregnancy represents a significant phase in the lives of women, particularly for those who are married. Thus, pregnancy necessitates specialized attention, especially concerning the fulfillment of energy and nutritional requirements. The quality of maternal dietary intake before and during pregnancy has the potential to influence the health of both the mother and her baby. Malnutrition during pregnancy can lead to various complications, affecting both the mother and the fetus, including issues like anemia, bleeding, and inadequate maternal weight gain. Maternal nutritional intake is influenced by a multitude of internal and external factors within the pregnant mother and her family, encompassing factors such as low levels of knowledge, social dynamics, and household income. This study aims to explore the correlation between the nutritional status of pregnant women and the family income level at the Ampel Health Center in Boyolali Regency. The research employs a quantitative approach utilizing an analytical survey method with a cross-sectional design. The study involved a sample size of 30 pregnant women. The results reveal that the majority of participants are aged between 20-35 years, predominantly in the second trimester of pregnancy, with 10 respondents (33.3%) in trimester II and 20 respondents (66.6%) in trimester III. The Spearman's rank correlation test yielded a p-value of 0.353, which is above the significance level of 0.05 (0.353 > 0.05). Nonetheless, there is no significant correlation between the nutritional status of pregnant women and the family income level at the Ampel Health Center in Boyolali Regency.
BI-RADS CLASSIFICATION FOR BREAST ULTRASOUND : A REVIEW Arizal Abdulloh; Ana Qomariyatun Ni'mah
PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID) Vol. 2 No. 2 (2023): APRIL
Publisher : Transpublika Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55047/comorbid.v2i2.840

Abstract

Breast cancer is the most common form of cancer in women worldwide. According to statistics from GLOBOCAN 2020, 1.2 million women are diagnosed with breast cancer each year, and 410,000 (35%) will die from this disease. Breast cancer is the most prevalent type of cancer among women in Indonesia, accounting for 30.8% of all female cancer cases in 2020 and causing 20.4% of female cancer-related deaths in the same year. Breast cancer screening plays a vital role in reducing deaths caused by breast cancer. Various breast cancer imaging techniques have been introduced for diagnosing breast cancer, such as Magnetic Resonance (MR) mammography, Ultrasound, Elastography, Mammography, and Automated Breast Ultrasound (ABUS). Ultrasound (US) and mammography are the two most important modalities for breast imaging. In younger women under the age of 35, ultrasound is the primary tool used to investigate breast problems. Even in the older age group, ultrasound plays a crucial role in breast imaging, particularly for the assessment of mass lesions. Breast ultrasound can be used for both screening and diagnostic purposes. Ultrasound evaluates breast tissue without the use of ionizing radiation or the injection of contrast material and is affordable, readily available, and well-tolerated by patients. The American College of Radiology (ACR) proposed the Breast Imaging Reporting and Data System (BI-RADS) to standardize the characterization of sonographic breast lesions according to five criteria categories: mass shape, orientation, margin, echo pattern, and posterior features.
COMPARED EFFECTIVENESS, SAFETY AND COST OF DEXMEDETOMIDINE WITH MIDAZOLAM: A REVIEW Nila Rusdi Rahayu; Siti Mutripah
PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID) Vol. 2 No. 2 (2023): APRIL
Publisher : Transpublika Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55047/comorbid.v2i2.881

Abstract

Dexmedetomidine, an alpha 2 receptor agonist sedative drug, has recently garnered attention as a viable alternative to midazolam, a widely used benzodiazepine for sedation in adult patients. The aim of this study was to conduct a comprehensive comparison of the clinical sedative efficacy, cost-effectiveness, and safety profiles of dexmedetomidine versus midazolam, utilizing a randomized controlled trial design. The search encompassed several databases, including PubMed, Scopus, Web of Knowledge, CINAHL, the United States National Library of Medicine, and Google Scholar for Systematic Reviews, using the keywords 'dexmedetomidine,' 'midazolam,' and 'effectiveness.' The findings revealed that dexmedetomidine demonstrated a more favorable safety profile, with a lower incidence of delirium compared to midazolam. In terms of effectiveness, no significant differences were observed between the two drugs for local sedation. Notably, adult patients treated with dexmedetomidine had a shorter Intensive Care Unit (ICU) stay (7 days) compared to those receiving midazolam (10 days). Similarly, pediatric ICU treatment indicated a shorter duration with dexmedetomidine (20 hours) as opposed to midazolam (38 hours). Regarding cost-effectiveness, dexmedetomidine emerged as a cost-saving option, being approximately 10% cheaper than midazolam for adult ICU patients. These findings collectively highlight the advantages of dexmedetomidine over midazolam, encompassing superior safety, effectiveness, and cost-efficiency, thus providing valuable insights for healthcare practitioners and decision-makers.

Page 1 of 1 | Total Record : 3